ArticleAnnals of biomedical engineering2026
The CathPilot: Usability and Feasibility Evaluation in Simulated-Use Endovascular Interventions.
Article in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Endovascular treatment of complex peripheral artery disease and chronic total occlusions remains a significant challenge. This is largely due to limited distal control of devices used and reliance on proximal manipulation with conventional catheters. To bridge this gap, we previously developed the CathPilot, a modular steerable catheter that integrates a self-expanding nitinol frame for local anchoring with a real-time graphical user interface that provides cross-sectional tip position feedback alongside fluoroscopy. This study compares the CathPilot with conventional non-steerable catheters in a simulated-use, within-subjects design. Eight interventional clinicians each performed three lesion-crossing attempts per device in a silicone phantom model of human vasculature. Silicone lesions were positioned in the left superficial femoral artery. Objective endpoints included lesion-crossing success, procedure time, fluoroscopy time, and radiation dose. Subjective assessments included the System Usability Scale (SUS) for perceived usability and NASA Task Load Index (NASA-TLX) for operator workload. Combining objective performance with human-factors instruments enabled a comprehensive assessment of the CathPilot's procedural usability against conventional catheters. CathPilot achieved a 92% lesion-crossing success rate with approximately 3 × improvement compared to conventional catheters. Clinician-level and lesion-level procedure times, and fluoroscopy times were significantly lower when using the CathPilot. Similarly, the NASA-TLX workload rating was significantly lower for CathPilot. Under simulated-use conditions, these findings indicate the potential of the CathPilot system to address endovascular revascularization challenges and demonstrate the added value of precise distal tip control, tracking, and support.
Indexed as
Identifiers
42426315What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.